Latest Breaking News On - Controlled trial evaluating - Page 1 : comparemela.com

The second round of late-breaking clinical trials were presented with results from three studies during the Vascular InterVentional Advances Conference, VIVA23, being held Oct. 30-Nov. 2 in Las Vegas, NV. Notably, results from Abbott’s LIFE-BTK randomized clinical trial (RCT) demonstrated that Esprit BTK (Abbott) reduces disease progression and helps improve medical outcomes compared to balloon angioplasty, the current state of care.

San franciscoCaliforniaUnited statesJapanNew zealandMarianne brodmannRobert looksteinRaghu kolluriWynn las vegasVascular interventional advances conferenceControlled trial evaluatingEluting resorbable scaffoldTranscatheter cardiovascular therapeuticsInfrapopliteal arteryNew england journalMonth results